The Research Of Enterprise Purchase And Stock Management Under OEM Bussiness Mode To Pharmaceutical Companies As An Example

OEM business mode has irreplaceable economical standing and effect in China economy development. According to customs statistics, the total amount of Chinese foreign trade is USD1.4 trillion in 2005, thereinto, USD762 billion is from export business. The amount of China's exportation climbed to No.4 in 2005, however, about half export commodities are manufactured under processing trade mode, this is to say, near to 50% commodities are produced under OEM mode.As per the statute printed by State Food&Drug Administration(SFDA), domestic GMP approved pharmaceutical companies are allowed to produce medicine under OEM business mode for foreign companies. Zhejiang Hisun Pharmaceutical Co,.Ltd., Suzhou Lida Pharmaceutical Co.,Ltd. had made some process for US Merck and US Wyeth. Along with the fast development of OEM business mode in Chinese pharmaceutical market, how to operate OEM business in this field is an important issue that Chinese pharmaceutical companies are facing.This article takes Biotech diagnostic manufacturing enterprise, Company A as research object, to summarize Purchase and Stock management that suitable for Company by analyzing the changes of Purchase management and Stock management accompanying the development of Company A as well as the advanced experience of Purchase and Stock management.